Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Rankning i aktier #39281
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Aktiekurs
$2.06
Senast synkroniserad: 2026-08-11
Marknadsvärde
$572.30K
Förändring (1 dag)
0.00%
Förändring (1 år)
-90.38%
Land
CA
Handel XORTX Therapeutics Inc. (XRTX)

Kategori

Historik för aktiesplit för XORTX Therapeutics Inc. (XRTX)
Aktien XORTX Therapeutics Inc. (symbol: XRTX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 14, 2026.
En XRTX-aktie köpt före Aug 14, 2026 motsvarar nu 0 XRTX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE